Nevirapine Tablet, Extended Release
Product Images NDC 33342-238

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Nevirapine (NDC 33342-238). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Nevirapine Er 100s Carton

This is a product description for Nevirapine Extended-Release Tablets, USP manufactured by Macleods Pharma. The package contains 100 tablets, each tablet containing 400 mg Nevirapine. The tablets must be swallowed whole and should not be chewed, crushed, or divided. Dosage information must be obtained from the package insert. The tablets should be stored at a temperature between 20° to 25°C (68° to 77°F) with excursions allowed to 15° to 30°C (59° to 86°F). The package is not child-resistant. The text also includes batch numbers, manufacturing locations, and other company-specific information.*

FDA Label Image

Nevirapine Er 30s Bottle

This is a medication called Nevirapine, USP. It comes in the form of extended-release tablets that must be swallowed whole and not chewed, crushed or divided. The usual dosage information can be found in the package insert. They should be stored at a controlled room temperature of 20°C to 25°C (68° to 77°F) and should be preserved in well-closed containers. The medication guide accompanies each patient. This drug is manufactured by Macleods Pharmaceuticals Ltd. for Macleods Pharma USA, Inc. in Princeton, NJ.*

FDA Label Image

Formula (Nevirapine Formula)

FDA Label Image

Str (Nevirapine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.